| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |